Developing standardized corticosteroid treatment for Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy

Published:2017-07 Issue: Volume:58 Page:34-39
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Guglieri Michela,Bushby Kate,McDermott Michael P.,Hart Kimberly A.,Tawil Rabi,Martens William B.,Herr Barbara E.,McColl Elaine,Wilkinson Jennifer^ORCID,Kirschner Janbernd,King Wendy M.,Eagle Michele,Brown Mary W.,Willis Tracey,Hirtz Deborah,Shieh Perry B.,Straub Volker^ORCID,Childs Anne-Marie,Ciafaloni Emma,Butterfield Russell J.,Horrocks Iain,Spinty Stefan^ORCID,Flanigan Kevin M.,Kuntz Nancy L.,Baranello Giovanni,Roper Helen^ORCID,Morrison Leslie^ORCID,Mah Jean K.,Manzur Adnan Y.,McDonald Craig M.,Schara Ulrike,von der Hagen Maja,Barohn Richard J.,Campbell Craig,Darras Basil T.,Finkel Richard S.,Vita Giuseppe,Hughes Imelda,Mongini Tiziana,Pegoraro Elena,Wicklund Matthew,Wilichowski Ekkehard,Bryan Burnette W.,Howard James F.,McMillan Hugh J.,Thangarajh Mathula,Griggs Robert C.

Funder

National Institutes of Health

Telethon

Muscular Dystrophy Association

Parent Project Muscular Dystrophy

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference41 articles.

1. Evidence-based path to newborn screening for Duchenne muscular dystrophy;Mendell;Ann. Neurol.,2012

2. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trails based on the natural history;Brooke;Muscle Nerve,1983